Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Sumeet Ambarkhane"'
Autor:
Johannes Duell, Kami J. Maddocks, Eva González-Barca, Wojciech Jurczak, Anna Marina Liberati, Sven de Vos, Zsolt Nagy, Aleš Obr, Gianluca Gaidano, Pau Abrisqueta, Nagesh Kalakonda, Marc André, Martin Dreyling, Tobias Menne, Olivier Tournilhac, Marinela Augustin, Andreas Rosenwald, Maren Dirnberger-Hertweck, Johannes Weirather, Sumeet Ambarkhane, Gilles Salles
Publikováno v:
Haematologica, Vol 999, Iss 1 (2021)
Not available.
Externí odkaz:
https://doaj.org/article/87ddd8a6674b4a1a85c63967777aba9a
Autor:
Grzegorz S. Nowakowski, Mark Winderlich, Sumeet Ambarkhane, Günter Fingerle-Rowson, Debarshi Dey, Stephan Parche, Sascha Tillmanns, Nuwan C. Kurukulasuriya, Bruce Feinberg, Gilles Salles, Nathan H. Fowler, Erika Meli, Claudia Castellino, Anna Maria Barbui, Maurizio Frezzato, Dario Marino, Thomas Rodgers, Pier Luigi Zinzani
Supplementary Methods, Tables, and Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cd5b909d20f5f86c1b0721fbf284605
https://doi.org/10.1158/1078-0432.23183827
https://doi.org/10.1158/1078-0432.23183827
Autor:
Grzegorz S. Nowakowski, Mark Winderlich, Sumeet Ambarkhane, Günter Fingerle-Rowson, Debarshi Dey, Stephan Parche, Sascha Tillmanns, Nuwan C. Kurukulasuriya, Bruce Feinberg, Gilles Salles, Nathan H. Fowler, Erika Meli, Claudia Castellino, Anna Maria Barbui, Maurizio Frezzato, Dario Marino, Thomas Rodgers, Pier Luigi Zinzani
Purpose:Tafasitamab, an Fc-modified, humanized, anti-CD19 monoclonal antibody, in combination with lenalidomide, demonstrated efficacy in transplant-ineligible patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL), in the sing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a29b8d138b8ff55969aafd4e29ede446
https://doi.org/10.1158/1078-0432.c.6664573.v1
https://doi.org/10.1158/1078-0432.c.6664573.v1
Autor:
Grzegorz S. Nowakowski, Dok Hyun Yoon, Anthea Peters, Patrizia Mondello, Erel Joffe, Isabelle Fleury, Richard Greil, Matthew Ku, Reinhard Marks, Kibum Kim, Pier Luigi Zinzani, Judith Trotman, Dan Huang, Eva E. Waltl, Mark Winderlich, Nuwan C. Kurukulasuriya, Sumeet Ambarkhane, Georg Hess, Gilles Salles
Publikováno v:
Clinical Cancer Research. 28:4003-4017
Purpose: In RE-MIND2 (NCT04697160), patient-level outcomes from the L-MIND study (NCT02399085) of tafasitamab plus lenalidomide were retrospectively compared with patient-level matched observational cohorts treated with National Cancer Care Network (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebab011fbb0db0e241089a4a48e57884
https://doi.org/10.1158/1078-0432.ccr-21-3648
https://doi.org/10.1158/1078-0432.ccr-21-3648
Autor:
Raul Cordoba, Thibaud Prawitz, Tracy Westley, Anuj Sharma, Sumeet Ambarkhane, Venediktos Kapetanakis, Lorenzo Sabatelli
Publikováno v:
Advances in Therapy. 39:2668-2687
Tafasitamab plus lenalidomide (TAFA + LEN) received accelerated US Food and Drug Administration approval and conditional European Medicines Agency approval for treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d126444963ccd8dc4b220943b20023bf
https://doi.org/10.1007/s12325-022-02094-5
https://doi.org/10.1007/s12325-022-02094-5
Autor:
Gilles Salles, Georg Hess, Sumeet Ambarkhane, Nuwan C. Kurukulasuriya, Mark Winderlich, Eva E. Waltl, Dan Huang, Judith Trotman, Pier Luigi Zinzani, Kibum Kim, Reinhard Marks, Matthew Ku, Richard Greil, Isabelle Fleury, Erel Joffe, Patrizia Mondello, Anthea Peters, Dok Hyun Yoon, Grzegorz S. Nowakowski
Supplementary Data from Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1930e700e550408af15df231fb5a4638
https://doi.org/10.1158/1078-0432.22487384
https://doi.org/10.1158/1078-0432.22487384
Autor:
Gilles Salles, Georg Hess, Sumeet Ambarkhane, Nuwan C. Kurukulasuriya, Mark Winderlich, Eva E. Waltl, Dan Huang, Judith Trotman, Pier Luigi Zinzani, Kibum Kim, Reinhard Marks, Matthew Ku, Richard Greil, Isabelle Fleury, Erel Joffe, Patrizia Mondello, Anthea Peters, Dok Hyun Yoon, Grzegorz S. Nowakowski
Supplementary Figure from Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac633b966e25188b2e8278adf36a2753
https://doi.org/10.1158/1078-0432.22487378
https://doi.org/10.1158/1078-0432.22487378
Autor:
Gilles Salles, Georg Hess, Sumeet Ambarkhane, Nuwan C. Kurukulasuriya, Mark Winderlich, Eva E. Waltl, Dan Huang, Judith Trotman, Pier Luigi Zinzani, Kibum Kim, Reinhard Marks, Matthew Ku, Richard Greil, Isabelle Fleury, Erel Joffe, Patrizia Mondello, Anthea Peters, Dok Hyun Yoon, Grzegorz S. Nowakowski
Purpose:In RE-MIND2 (NCT04697160), patient-level outcomes from the L-MIND study (NCT02399085) of tafasitamab plus lenalidomide were retrospectively compared with patient-level matched observational cohorts treated with National Cancer Care Network (N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33449120f3d5064cb2e5d1c9a51e9be6
https://doi.org/10.1158/1078-0432.c.6532508
https://doi.org/10.1158/1078-0432.c.6532508
Autor:
Marinela Augustin, Johannes Duell, Sabine Geiger, Jan Endell, Aleš Obr, Sumeet Ambarkhane, Andreas Rosenwald, Ian M. Silverman, Hao Liu
Publikováno v:
Leukemia & Lymphoma. 63:468-472
CD19 is an important target for novel anti-lymphoma treatments as it is broadly and homogenously expressed across many B-cell malignancies [1,2]. Approximately 30–50% of patients with diffuse large...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aa283faffe7f878264cf1ca64a9565a
https://doi.org/10.1080/10428194.2021.1986219
https://doi.org/10.1080/10428194.2021.1986219
Autor:
Malin Lindstedt, Peter Ellmark, Aastha Sobti, Karin Enell Smith, Yago Pico de Coaña, Sumeet Ambarkhane
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c00559db576cdd5327501c00db9e4082
https://doi.org/10.1136/jitc-2022-sitc2022.0035
https://doi.org/10.1136/jitc-2022-sitc2022.0035